Procicept LLidocaine 4% (Nocicept Technologies, Inc.)
Welcome to the PulseAid listing for the Procicept L drug offered from Nocicept Technologies, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Nocicept Technologies, Inc. |
NON-PROPRIETARY NAME: | Lidocaine and Menthol |
SUBSTANCE NAME: | LIDOCAINE; MENTHOL |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | TOPICAL |
DOSAGE FORM: | LIQUID |
MARKETING CATEGORY NAME: | OTC MONOGRAPH NOT FINAL |
START MARKETING DATE: | 2017-02-01 |
END MARKETING DATE: | 2018-02-20 |
Procicept L Lidocaine 4% HUMAN OTC DRUG Details:
Item Description | Procicept L Lidocaine 4% from Nocicept Technologies, Inc. |
LABELER NAME: | Nocicept Technologies, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | .04; .01(g/g; g/g) |
START MARKETING DATE: | 2017-02-01 |
END MARKETING DATE: | 2018-02-20 |
PRODUCT ID: | 70458-101_aebaf1dd-56ce-4c1e-9e76-fa39eb6fca9e |
PRODUCT NDC: | 70458-101 |
APPLICATION NUMBER: | part356 |
Other LIDOCAINE; MENTHOL Pharmaceutical Manufacturers / Labelers: